UK small-cap RNS · 9 Oct 2025
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Date | Company | Mcap | Holder | Stake | Crossed | |
|---|---|---|---|---|---|---|
| 9 Oct | Ashmore Group ASHM | £1,442m | BlackRock, Inc. | 5.89% → 5.72% | ||
| 9 Oct | Chemring Group CHG | £1,460m | BlackRock, Inc. | 7.9% → 7.75% | ||
| 9 Oct | Applied Nutrition Plc APN | £735m | UBS Group AG-Investment Bank & Global Wealth Management | 5.79% → 0% | 5% | |
| 9 Oct | Renalytix RENX | £40m | UBS Group AG - Investment Bank & Global Wealth Management | 8.64% → 5.34% | ||
| 9 Oct | Foxtons Group FOXT | £110m | CLEARBRIDGE INVESTMENT MANAGEMENT LIMITED | 5.12% → 4.99% | 5% | |
| 9 Oct | PureTech Health PRTC | £268m | Citigroup Inc. | 5.71% → 5.66% | ||
| 9 Oct | Gateley (Holdings) GTLY | £101m | Octopus Investments Limited | 13.01% → 12.99% |
Notifications of major holdings (TR-1): a holder crossing 3%, 5%, 10% … of the voting rights. Key shows stakes of 5% and more; the 3–5% band (mostly index funds) is under All. Transfers inside a group are left out.